SMTL ID : 5wjj.1

Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 MAP Kinase Inhibitors

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x AQY: N-{4-[2-(4-fluoro-3-methylphenyl)imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl}-2-methyl-1-oxo-1lambda~5~-pyridine-4-carboxamide(Non-covalent)

AQY.1: 19 residues within 4Å: Chain A: V.35, Y.40, V.43, A.56, K.58, L.80, L.91, L.109, V.110, T.111, H.112, L.113, M.114, G.115, F.174, G.175, L.176, A.177, H.179 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:V.35, A:Y.40, A:Y.40, A:K.58, A:L.80, A:F.174, A:F.174, A:F.174, A:L.176 Hydrogen bonds: A:K.58, A:M.114, A:M.114, A:A.177, A:H.179 pi-Stacking: A:F.174

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kaieda, A. et al., Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors. Bioorg. Med. Chem. (2018)

Release Date

2018-01-17

Peptides

Mitogen-activated protein kinase 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 14

Related Entries With Identical Sequence